JP2015519403A5 - - Google Patents

Download PDF

Info

Publication number
JP2015519403A5
JP2015519403A5 JP2015517461A JP2015517461A JP2015519403A5 JP 2015519403 A5 JP2015519403 A5 JP 2015519403A5 JP 2015517461 A JP2015517461 A JP 2015517461A JP 2015517461 A JP2015517461 A JP 2015517461A JP 2015519403 A5 JP2015519403 A5 JP 2015519403A5
Authority
JP
Japan
Prior art keywords
region
controlled release
mucosa
release polymer
mucoadhesive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015517461A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015519403A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/045976 external-priority patent/WO2013188819A2/en
Publication of JP2015519403A publication Critical patent/JP2015519403A/ja
Publication of JP2015519403A5 publication Critical patent/JP2015519403A5/ja
Pending legal-status Critical Current

Links

JP2015517461A 2012-06-14 2013-06-14 活性剤送達のための粘膜付着性デバイス Pending JP2015519403A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201261659781P 2012-06-14 2012-06-14
US201261659784P 2012-06-14 2012-06-14
US61/659,781 2012-06-14
US61/659,784 2012-06-14
US201261671287P 2012-07-13 2012-07-13
US61/671,287 2012-07-13
PCT/US2013/045976 WO2013188819A2 (en) 2012-06-14 2013-06-14 Mucoadhesive devices for delivery of active agents

Publications (2)

Publication Number Publication Date
JP2015519403A JP2015519403A (ja) 2015-07-09
JP2015519403A5 true JP2015519403A5 (https=) 2016-07-14

Family

ID=48748504

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015517461A Pending JP2015519403A (ja) 2012-06-14 2013-06-14 活性剤送達のための粘膜付着性デバイス

Country Status (5)

Country Link
US (4) US20150174076A1 (https=)
EP (1) EP2861220A2 (https=)
JP (1) JP2015519403A (https=)
CA (1) CA2915358A1 (https=)
WO (1) WO2013188819A2 (https=)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3191083T3 (pl) * 2014-09-11 2021-07-12 Gelita Ag Cząstki żelatyny/pektyny
DK3006045T3 (en) 2014-10-07 2017-07-17 Cyprumed Gmbh Pharmaceutical formulations for oral administration of peptide or protein drugs
EP3359181A1 (en) 2015-10-07 2018-08-15 Cyprumed GmbH Pharmaceutical formulations for the oral delivery of peptide drugs
WO2017136745A1 (en) * 2016-02-05 2017-08-10 Entrega Inc. Oral dosage form with drying agent for delivery of active agent
CA3015172A1 (en) 2016-02-18 2017-08-24 Privo Technologies, Inc. Two-stage microparticle-based therapeutic delivery system and method
ITUA20161822A1 (it) * 2016-03-18 2017-09-18 Indena Spa Composizioni utili nella prevenzione e/o nel trattamento di patologie del cavo orale, delle prime vie aeree e dell’esofago
WO2018065634A1 (en) 2016-10-07 2018-04-12 Cyprumed Gmbh Pharmaceutical compositions for the nasal delivery of peptide or protein drugs
KR102592782B1 (ko) 2017-01-23 2023-10-20 에이에프와이엑스 테라퓨틱스 에스에이 전기방사 섬유에 기반한 2층 제품의 제조 방법
US20180235899A1 (en) * 2017-02-17 2018-08-23 Privo Technologies, Inc. Particle-based multi-layer therapeutic delivery device and method
US10478403B1 (en) 2017-05-03 2019-11-19 Privo Technologies, Inc. Intraoperative topically-applied non-implantable rapid release patch
US11541015B2 (en) 2017-05-17 2023-01-03 Massachusetts Institute Of Technology Self-righting systems, methods, and related components
WO2018213579A1 (en) 2017-05-17 2018-11-22 Massachusetts Institute Of Technology Self-actuating articles
WO2019004088A1 (ja) * 2017-06-27 2019-01-03 株式会社バイオセレンタック 粘膜付着性経口製剤
EP3773475A1 (en) 2018-04-06 2021-02-17 Cyprumed GmbH Pharmaceutical compositions for the transmucosal delivery of therapeutic peptides and proteins
AU2019269636A1 (en) 2018-05-17 2020-11-19 Massachusetts Institute Of Technology Systems for electrical stimulation
EP4696361A3 (en) 2019-02-01 2026-04-15 Massachusetts Institute of Technology Systems and methods for liquid injection
CN114340615A (zh) 2019-08-12 2022-04-12 麻省理工学院 用于施用治疗剂的制品和方法
US11793980B2 (en) 2019-08-31 2023-10-24 Celero Systems, Inc. Intestinal attachment device
US11541216B2 (en) 2019-11-21 2023-01-03 Massachusetts Institute Of Technology Methods for manufacturing tissue interfacing components
WO2022049310A1 (en) 2020-09-07 2022-03-10 Cyprumed Gmbh Improved pharmaceutical formulations of glp-1 receptor agonists
BR112023018524A2 (pt) 2021-03-15 2023-11-21 Epitomee Medical Ltd Dispositivos expansíveis para entrega de agentes ativos aos tecidos
KR20240041285A (ko) 2021-06-01 2024-03-29 프리보 테크놀로지스, 인코포레이티드 향상된 2단계 미세입자 기반 국소 치료제 전달 시스템
EP4486366A1 (en) 2022-03-03 2025-01-08 Cyprumed GmbH Improved oral pharmaceutical formulations of therapeutic peptides and proteins
CA3268033A1 (en) 2022-09-21 2024-03-28 Epitomee Medical Ltd. Ingestable, self-expanding devices that can disintegrate in a controllable manner

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56100714A (en) * 1980-01-16 1981-08-12 Teijin Ltd Pharmaceutical adhering to oral mucous membrane or nasal mucous membrane
US5766620A (en) * 1995-10-23 1998-06-16 Theratech, Inc. Buccal delivery of glucagon-like insulinotropic peptides
US6159497A (en) * 1998-10-30 2000-12-12 Noven Pharmaceuticals, Inc. Patch applicator
AU2002319653A1 (en) * 2001-07-20 2003-03-03 Samir Mitragotri Method for oral drug delivery
US20050027016A1 (en) * 2002-02-07 2005-02-03 Fahl Kathleen L Polyamine compounds and compositions for use in conjection with cancer therapy
WO2005009357A2 (en) * 2003-07-23 2005-02-03 Pr Pharmaceuticals, Inc. Controlled release compositions
BRPI0619806A2 (pt) * 2005-12-13 2011-10-18 Biodelivery Sciences Int Inc dispositivo para fornecimento de fármacos transmucosal resistente ao abuso
US20090110717A1 (en) * 2006-05-02 2009-04-30 Amarjit Singh Transmucosal composition
JP5005422B2 (ja) * 2007-05-09 2012-08-22 株式会社エンプラス 射出成形ギヤ
CA2817982C (en) * 2010-11-15 2020-06-30 The Regents Of The University Of Michigan Controlled release mucoadhesive systems
WO2012136218A1 (en) * 2011-04-04 2012-10-11 Coloplast A/S An adhesive patch

Similar Documents

Publication Publication Date Title
JP2015519403A5 (https=)
Morales et al. Manufacture and characterization of mucoadhesive buccal films
HK1219096A1 (zh) 抗篡改的药物制剂
EA201400972A1 (ru) Лекарственные формы немедленного высвобождения с защитой от несанкционированного применения
RU2700926C2 (ru) Трансдермальные системы, предотвращающие злоупотребление и неправильное употребление
EP4576939A3 (en) Aerosol delivery device with improved fluid transport
WO2011107855A3 (en) Sustained release oral liquid suspension dosage form
WO2014102613A3 (en) Device for disposal and neutralization of pharmaceutical agents
AR073704A1 (es) Sistema de administracion transdermal de droga para principios activos liquidos que tiene una capa de matriz adhesiva que incluye un ingrediente farmaceutico activo que es seleccionado entre selegilina y rivastigmina
JP2012085643A5 (https=)
WO2013038268A8 (en) Tamper resistant immediate release formulations
CN110035744A (zh) 一种尼拉帕尼缓控释药物组合物及其用途
JP2014528431A5 (https=)
PE20142035A1 (es) Formulacion compuesta que comprende un comprimido esferoidal de multiples unidades (must) encapsulada en una capsula dura y metodo para preparar la misma
EP3556369A4 (en) PROLONGED-RELEASE ORAL PHARMACEUTICAL COMPOSITION OF OLAPARIB AND USES THEREOF
CO6400184A2 (es) Formulaciones galénicas de compuestos orgánicos
JP2013047264A5 (https=)
WO2015003479A3 (zh) 一种适用于婴幼儿及儿童的口服固体颗粒及其制备方法
WO2014130866A3 (en) Targeted buccal delivery comprising cisplatin-loaded chitosan nanoparticles
CR20150077A (es) Composición farmacéutica oral en forma de microesferas y proceso de elaboración
JP2014526519A5 (https=)
WO2014130553A3 (en) Tablet dosage form comprising ritonavir and lopinavir
EA201400737A1 (ru) Система доставки на основе множества пеллет с немедленным высвобождением активного вещества
JP2015508411A5 (https=)
WO2012092486A3 (en) Modified release benzimidazole formulations